StockData
Enovis CORP logo

Enovis CORP (ENOV) stock

ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3066% below fair value
$27.10−0.12 (-0.44%)

Close on Nov 18, 2026Market cap $1.56BP/E –Yield –

Enovis total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Enovis's total debt was $1.28B at Jul 3, 2026. For fiscal 2025 it was $1.30B, down 2.5% from the year before. Over ten years it grew -0.9% a year on average. The highest annual figure on record is $2.31B in fiscal 2019.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.30B-2.5%
FY2024Dec 31, 2024$1.33B+185.2%
FY2023Dec 31, 2023$466.16M+79.8%
FY2022Dec 31, 2022$259.28M-87.6%
FY2021Dec 31, 2021$2.09B-6.5%
FY2020Dec 31, 2020$2.23B-3.5%
FY2019Dec 31, 2019$2.31B+93.1%
FY2018Dec 31, 2018$1.20B+12.9%
FY2017Dec 31, 2017$1.06B-17.9%
FY2016Dec 31, 2016$1.29B-8.8%
FY2015Dec 31, 2015$1.42B-7.8%
FY2014Dec 31, 2014$1.54B+3.3%
FY2013Dec 31, 2013$1.49B-14.0%
FY2012Dec 31, 2012$1.73B+1449.8%
FY2011Dec 31, 2011$111.52M+35.2%
FY2010Dec 31, 2010$82.50M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jul 3, 2026$1.28B-7.8%
Q1 FY2026Apr 3, 2026$1.33B-4.4%
Q4 FY2025Dec 31, 2025$1.30B-2.5%
Q3 FY2025Oct 3, 2025$1.36B+1.0%
Q2 FY2025Jul 4, 2025$1.39B+3.7%
Q1 FY2025Apr 4, 2025$1.39B+3.7%
Q4 FY2024Dec 31, 2024$1.33B+185.2%
Q3 FY2024Sep 27, 2024$1.35B+240.6%
Q2 FY2024Jun 28, 2024$1.34B+236.1%
Q1 FY2024Mar 29, 2024$1.34B+369.7%
Q4 FY2023Dec 31, 2023$466.16M+79.8%
Q3 FY2023Sep 29, 2023$395.00M-12.1%
Q2 FY2023Jun 30, 2023$400.00M-11.0%
Q1 FY2023Mar 31, 2023$285.00M-86.2%
Q4 FY2022Dec 31, 2022$259.28M-87.6%
Q3 FY2022Sep 30, 2022$449.22M-72.4%
Q2 FY2022Jul 1, 2022$449.46M-71.9%
Q1 FY2022Apr 1, 2022$2.07B-6.3%
Q4 FY2021Dec 31, 2021$2.09B-6.5%
Q3 FY2021Oct 1, 2021$1.63B-26.7%
Q2 FY2021Jul 2, 2021$1.60B-28.9%
Q1 FY2021Apr 2, 2021$2.21B-13.0%
Q4 FY2020Dec 31, 2020$2.23B-3.5%
Q3 FY2020Oct 2, 2020$2.22B-45.0%
Q2 FY2020Jul 3, 2020$2.25B-45.4%
Q1 FY2020Apr 3, 2020$2.54B-39.1%
Q4 FY2019Dec 31, 2019$2.31B+93.1%
Q3 FY2019Sep 27, 2019$4.03B+253.1%
Q2 FY2019Jun 28, 2019$4.12B+283.5%
Q1 FY2019Mar 29, 2019$4.17B+269.9%
Q4 FY2018Dec 31, 2018$1.20B+12.9%
Q3 FY2018Sep 28, 2018$1.14B-14.8%
Q2 FY2018Jun 29, 2018$1.07B-19.2%
Q1 FY2018Mar 31, 2018$1.13B+6.3%
Q4 FY2017Dec 31, 2017$1.06B-17.9%
Q3 FY2017Sep 29, 2017$1.34B-3.2%
Q2 FY2017Jun 30, 2017$1.33B–
Q1 FY2017Mar 31, 2017$1.06B–
Q4 FY2016Dec 31, 2016$1.29B–
Q3 FY2016Sep 30, 2016$1.39B–

More Enovis figures

See a number that looks wrong?